YOUNIS HUSAM (Chief Scientific Officer) received a stock award from ATRIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/22/2026ACC: 0001193125-26-170906
Officer· Chief Scientific Officer
Since Feb 2026
+90K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
90K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
132.4%
4/20/2026
22.66K→52.66K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/20/2026 | A · Award | +30K | — | — | 132.4% | 22.66K | 52.66K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
60K shares
Shares
+60K
Strike price
14.30
Held after
60K
Exercisable
—
4/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock60K shares | 4/20/2026 | A · Award | +60K | 14.30 | — | 60K |